Abuse of Amphetamines and Structural Abnormalities in the Brain.pdf - Drugs Forum
Drugs-Forum  
News Groups Blog Forum Chat Video Audio Images Documents Wiki Home
Go Back   Drugs Forum > VARIOUS DRUG RELATED TOPICS > Recovery and addiction > (Meth) Amphetamine addiction
Register Tags Mark Forums Read

Notices

(Meth) Amphetamine addiction Support for coping with Amphetamine addiction and Amphetamine addiction treatment. Amphetamines includes Meth & XTC.

Reply
 
Thread Tools Display Modes
  #1  
Old 12-04-2009, 08:49
Gradient's Avatar
Gradient Gradient is offline
Gradient is strappado
Palladium MemberDonating
 
Join Date: 09-11-2007
Location: United States
Posts: 645
Blog Entries: 1
Gradient must mainline MedlineGradient must mainline MedlineGradient must mainline MedlineGradient must mainline MedlineGradient must mainline MedlineGradient must mainline MedlineGradient must mainline MedlineGradient must mainline MedlineGradient must mainline MedlineGradient must mainline MedlineGradient must mainline Medline
Points: 10,182, Level: 14 Points: 10,182, Level: 14 Points: 10,182, Level: 14
Activity: 9% Activity: 9% Activity: 9%
Abuse of Amphetamines and Structural Abnormalities in the Brain.pdf

A new entry has been added to File Archive

Description:
We review evidence that structural brain abnormalities are associated with abuse of amphetamines. A brief history of amphetamine use/abuse and evidence for toxicity is followed by a summary of findings from structural magnetic resonance imaging (MRI) studies of human subjects who had abused amphetamines and children who were exposed to amphetamines in utero. Evidence comes from studies that used a variety of techniques including manual tracing, pattern matching, voxel-based, tensor-based, or cortical thickness mapping, quantification of white matter signal hyperintensities, and diffusion tensor imaging. Ten studies compared controls to individuals who were exposed to methamphetamine. Three studies assessed individuals exposed to 3-4-methylenedioxymethamphetamine (MDMA). Brain structural abnormalities were consistently reported in amphetamine abusers, as compared to control subjects. These included lower cortical gray matter volume and higher striatal volume than control subjects. These differences might reflect brain features that could predispose to substance dependence. High striatal volumes might also reflect compensation for toxicity in the dopamine-rich basal ganglia. Prenatal exposure was associated with striatal volume that was below control values, suggesting that such compensation might not occur in utero. Several forms of white matter abnormality are also common and may involve gliosis. Many of the limitations and inconsistencies in the literature relate to techniques and cross-sectional designs, which cannot infer causality. Potential confounding influences include effects of pre existing risk/protective factors, development, gender, severity of amphetamine abuse, abuse of other drugs, abstinence, and differences in lifestyle. Longitudinal designs in which multimodal datasets are acquired and are subjected to multivariate analyses would enhance our ability to provide general conclusions regarding the associations between amphetamine abuse and brain structure.

To check it out, rate it or add comments, visit Abuse of Amphetamines and Structural Abnormalities in the Brain.pdf
The comments you make there will appear in the posts below.
Reply With Quote
Reply

Bookmarks

Tags
amphetamines abuse, amphetamines brain, amphetamines damage, amphetamines long term, long term effects of amphetamines

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Amphetamines and MDMA: The Brain's Structural Abnormalities from Abuse Gradient Pharmacology 0 05-04-2009 06:11


Sitelinks: Site Functions:

All times are GMT +1. The time now is 19:32.


Copyright: Substance Information Network 2003 - 2009, All rights reserved